Telescope Innovations Strengthens Senior Management: Henry Dubina Appointed as CEO, Dr. Jason Hein as CTO, John Kirincic as CFO, Deborah Cotter as Corporate Secretary
February 15, 2024 — We welcome Henry Dubina as CEO, John Kirincic as CFO, and Deborah Cotter as Corporate Secretary. Jason Hein transitions to CTO.
Mettler Toledo and Telescope Innovations Agree to Globally Distribute Telescope’s Flagship Product, DirectInject-LC™
February 5, 2024 — We have signed a Distribution Agreement with METTLER TOLEDO for Telescope’s online chemistry sampling and analysis product, the DirectInject-LC™.
Telescope Innovations Presents Results of First Fiscal Quarter 2024
January 30, 2024 — The Company generated revenues of $1.50 M for a net income of $215,000, exceeding its prior records.
Telescope Innovations Files Game-Changing Provisional Patent to Purify Battery Materials
January 23, 2024 — Telescope announces it has filed a provisional patent application on a disruptive new technique to purify lithium carbonate.
Telescope Innovations Reports Strong Growth in Fiscal Year 2023
December 22, 2023 — The Company generated revenues of $2.82 M, representing an increase of 375% over the previous fiscal year.
Telescope Innovations Develops New IP for the Production of Battery Materials
December 18, 2023 — Telescope has invented a low-temperature method of generating lithium sulfide from brine-sourced lithium chemicals.
Telescope Innovations and Mott Corporation Initiate Technology Partnership
October 30, 2023 — Telescope and Mott plan to develop and commercialize a novel robotic sampling probe for automated chemistry analysis.
Telescope Innovations Product Deployed by 13 Pharma Giants in First Year
October 4, 2023 — Telescope’s flagship technology, Direct Inject Liquid Chromatography (DILC), has been deployed at 13 of the top 20 pharmaceutical companies in the world.
Telescope Innovations is Granted a Canadian Patent on Chemical Synthesis Route
August 28, 2023 — Telescope’s first Canadian patent describes a scalable manufacturing process to produce pharmaceutically-relevant indole compounds.
Telescope Announces Stock Option Grants
August 3, 2023 — Telescope has granted 800,000 incentive stock options to certain directors of the Company in accordance with the Company’s incentive stock option plan.
